NCT06816394 Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS) Status NOT_YET_RECRUITING Phase PHASE2
NCT06814496 Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06788938 Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms Status RECRUITING Phase PHASE2
NCT06776250 Study of How Safe and Effective Tarlatamab is in Brain Cancers Status RECRUITING Phase PHASE2
NCT06761703 A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss Status COMPLETED Phase N/A
NCT06747949 A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) Status RECRUITING Phase PHASE3
NCT06745323 A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06700343 Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06691984 Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06680622 Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06674941 A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants Status COMPLETED Phase PHASE1
NCT06660810 Neoadjuvant Intralesional Injection of Talimogene Laherparepvec Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06660173 A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06649006 Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) Status COMPLETED Phase PHASE1
NCT06637371 A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06613100 Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer Status RECRUITING Phase PHASE1
NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] Status COMPLETED Phase N/A
NCT06598306 Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308) Status RECRUITING Phase PHASE1